Singapore’s Thrixen raises $7M in funding round co-led by 22Health Ventures and John Ballantyne
Thrixen, a Singapore-based medical technology start-up, has on Monday announced the successful close of an oversubscribed funding round, raising $7 million capital to accelerate the development of its innovative diagnostic technology platform for multiplex point of care testing.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed